Achondroplasia is an autosomal dominant disorder characterized by impaired bone growth due to mutations in the FGFR3 gene, leading to disproportionate dwarfism, particularly affecting the growth of long bones. It has a prevalence of approximately 1 in 25,000 to 50,000 births, with distinctive clinical features including delayed motor milestones, disproportionally short limbs, and characteristic skull shapes. There is currently no cure for achondroplasia, and treatment primarily focuses on managing associated complications and supportive care.